 Name: ___          Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  M  Service: MEDICINE  Allergies: Morphine / Coricidin HBP  Attending: ___.  Chief Complaint: confusion, altered mental status  Major Surgical or Invasive Procedure: Chest tube placements

 History of Present Illness: ___ y/o M with PMhx of CAD s/p CABG in ___, NSTEMI, systolic CHF (EF 35-40%), PVD s/p bypass, CKD stage III, history of LLE DVT s/p IVC filter, chronic SDH, Dementia and frequent falls who was sent in from his SNF due to worsening confusion over the last few days since recent fall. Pt was initially seen at ___ and referred to ___ due to concern for acute on chronic component to his SDH. Pt was seen by NSG in the ED and serial head CTs have been unchanged, not felt to require any intervention or ICU level monitoring. ED eval was notable for positive UA and concern for possible LLE cellulitis.  Pt was treated with Clindamycin and Cefriaxone prior to admission to the floor.

On arrival to the floor, pt was denying any complaints and was asking for breakfast.  He denies any CP, SOB, HA, fevers, cough, abd pain, dysuria ___ edema.  No ___ pain and reports walking with walker at baseline. He does report some constipation and was noted to have a stage II sacral decub today. Additional history was obtained from his ___ who reports that he has frequent falls and is often in a wheelchair at the SNF because of his fall risk. She feels that he may not be a reliable historian and often minimizes symptoms.

12 pt ROS otherwise negative 

 Past Medical History: - Systolic CHF (EF 35-40%, ___  - Dementia  - UGIB ___ s/p endoscopic control of duodenal ulcer hemorrhage  - PVD s/p right limb ischemia s/p Right Femoral-Peroneal Bypass with Left Reversed Saphenous Vein Graft ___  - NSTEMI (Type II; ___  - CABG x 2 in ___, ___-LAD, s/p angioplasty x 5  - Hypertension  - Hyperlipidemia  - Diabetes mellitus, type II  - Left-sided Sensory Seizures - well controlled on Dilantin  described by the patient as a tingling in his left cheek and left arm from shoulder to elbow, sometimes spreading down his torso and left leg. He has never had a generalized seizure (other than possibly one in the setting of taking morphine where he had bilateral arm haking)  - CKD, stage III  - Arthritis  - Chronic subdural hematoma  - History of LLE DVT, ___  Social History: ___ Family History: (per OMR) - negative for stroke, seizure, movement disorders, known neurological conditions other than migarine - positive for CAD/MIs (mother, father), migraine (mother)

 Physical Exam: Admission exam VITALS: 97.9 HR 95 BP 119/65 RR 18 Sats 97% RA GENERAL: Alert elderly male in no apparent distress EYES: Anicteric, pupils equally round ENT: MMM CV: RRR RESP: Crackles at LLL > RLL, no wheezes GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. GU: No suprapubic fullness or tenderness to palpation SKIN: BLE erythema and edema, L>R, mild warmth without TTP NEURO: oriented to city, reports year as ___, month of ___ EOMI, speech fluent, no facial asymmetry, HOH but moves all limbs, sensation to light touch grossly intact throughout

Discharge exam GENERAL: Alert and in no apparent distress, resting in bed EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Breathing is non-labored, mildly diminished at bases, occasional ___ rhonchi, no wheezing, L chest tube has now been removed, dressing c/d/I, serosang drainage GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs, L leg swollen > R leg, chronic SKIN: venous stasis dermatitis over ___ NEURO: alert, oriented to self (name, DOB), not oriented to place or time. PSYCH: at times uncooperative  Pertinent Results: Admission labs ___ 10:25AM BLOOD WBC-11.3*# RBC-3.58* Hgb-10.8* Hct-32.9* MCV-92 MCH-30.2 MCHC-32.8 RDW-14.3 RDWSD-48.4* Plt ___ ___ 10:25AM BLOOD Glucose-224* UreaN-44* Creat-1.2 Na-138 K-4.0 Cl-93* HCO3-30 AnGap-15

URINE CULTURE (Final ___:    ESCHERICHIA COLI.  >100,000 CFU/mL.      Cefazolin interpretative criteria are based on a dosage regimen of     2g every 8h. 

               SENSITIVITIES: MIC expressed in MCG/ML            _________________________________________________________               ESCHERICHIA COLI               |  AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM--  16 I CEFAZOLIN-------------  <=4 S CEFEPIME--------------  <=1 S CEFTAZIDIME-----------  <=1 S CEFTRIAXONE-----------  <=1 S CIPROFLOXACIN---------  0.5 S GENTAMICIN------------ =>16 R MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO-----  <=4 S TOBRAMYCIN------------   2 S TRIMETHOPRIM/SULFA---- =>___hest ___ IMPRESSION:   1. 5.1 x 7.3 cm area of dense airspace opacification with rounded margins in the left lower lobe with adjacent patchy peribronchial opacities and small pleural effusion is new compared to the prior chest radiograph of ___, but grossly unchanged since the more recent radiographs dating back to ___. The most worrisome differential consideration is malignancy. Alternatively, this could be due to infection. Rounded atelectasis is possible but less likely.   2. A 0.5 x 1.2 cm rounded density along the dependent portion of the right mainstem bronchus probably represents secretions, although an endobronchial lesion cannot be entirely excluded.   3. 2 mm nodule in the right lung apex.   RECOMMENDATION(S): Recommend empiric therapy with short term repeat CT examination with contrast after completion of therapy. If this finding persists or worsens at that time, PET-CT or direct tissue sampling should be considered. The area of dependent density in the right mainstem bronchus can be followed up at that time as well. 

CT C/A/P ___ IMPRESSION:   1. Left lower lobe collapse, new since the prior study. An underlying infectious process cannot be excluded. 2. New loculated left pleural effusions abutting the left upper and left lower lobes. 

Radiology ReportCT CHEST W/O CONTRASTStudy Date of ___ 6:08 ___  ___ 6:___HEST W/O CONTRAST Clip # ___  Reason: ___ year old man with L-sided loculated pleural effusions s/p pigtail placement ___ ___. ?residual effusion UNDERLYING MEDICAL CONDITION:  Loculated pleural effusiion REASON FOR THIS EXAMINATION:  ___ year old man with L-sided loculated pleural effusions s/p pigtail placement  ___ ___. ?residual effusion CONTRAINDICATIONS FOR IV CONTRAST:  CKD Final Report EXAMINATION: CT CHEST W/O CONTRAST  INDICATION: Loculated pleural effusiion// ___ year old man with L-sided loculated pleural effusions s/p pigtail placement ___ ___. ?residual effusion  TECHNIQUE: Serial axial sections were performed through the chest. Reconstructed coronal and sagittal images were generated. Axial maximal intensity projection reformatted images were performed.  DOSE: Acquisition sequence:  1) Spiral Acquisition 6.5 s, 34.2 cm; CTDIvol = 8.3 mGy (Body) DLP = 286.7 mGy-cm. Total DLP (Body) = 287 mGy-cm.  COMPARISON: CT scan of the chest from ___.  FINDINGS:  NECK, THORACIC INLET, AXILLAE, CHEST WALL: The thyroid gland is unremarkable. There is no supraclavicular or axillary adenopathy.  UPPER ABDOMEN: The study is not tailored for evaluation of the upper abdomen however the upper abdomen appears stable when compared to the recent study.  MEDIASTINUM: There is a stable sub aortic 1 cm lymph node.  There are several additional smaller mediastinal lymph nodes which are within the range of normal in size for cross-sectional imaging.  HEART and PERICARDIUM: The patient is status post sternotomy and CABG. Coronary artery and cardiac valve calcification is re-demonstrated. PLEURA: There is a loculated left pleural effusion. There is a left-sided pigtail catheter. Previously seen large fluid pocket has resolved. There is persistence of a smaller loculated air and fluid collection which appears similar. LUNG:  1. PARENCHYMA: There is centrilobular emphysema, most prominent in the upper lobes. Atelectatic changes are noted in the lingula and left lower lobe this is not significantly changed. 2. AIRWAYS: There is likely mild bronchial wall thickening in the right lower lobe. 3. VESSELS: The aorta is atherosclerotic and tortuous. CHEST CAGE: Degenerative changes are evident.  IMPRESSION:  There is a left pigtail catheter with resolution of a previously noted large loculated fluid pocket. Persistence of smaller loculated air-fluid collection and small left effusion with associated atelectasis. Emphysematous changes. Vascular and heart valve calcification. Stable sub aortic 1 cm lymph node.  ___, MD electronically signed on SAT ___ 8:53 ___

___ 03:50PM PLEURAL ___ Polys-75* Lymphs-3* Monos-22* ___ 03:37PM PLEURAL ___ Polys-92* Lymphs-3* Monos-3* Eos-2* ___ 03:50PM PLEURAL TotProt-4.2 Glucose-94 LD(LDH)-4010 Amylase-22 ___ Misc-BODY FLUID ___ 03:37PM PLEURAL TotProt-4.6 Glucose-194 LD(LDH)-831 Albumin-2.2 Cholest-99 ___ 03:37PM OTHER BODY FLUID Misc-BODY FLUID

___ 3:37 pm PLEURAL FLUID

  GRAM STAIN (Final ___:    2+  ___ per 1000X FIELD):  POLYMORPHONUCLEAR LEUKOCYTES.    NO MICROORGANISMS SEEN. 

  FLUID CULTURE (Final ___:  NO GROWTH. 

  ANAEROBIC CULTURE (Final ___:  NO GROWTH. 

  FUNGAL CULTURE (Preliminary):  NO FUNGUS ISOLATED. 

  ACID FAST SMEAR (Final ___:    NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. 

  ACID FAST CULTURE (Preliminary):  NO MYCOBACTERIA ISOLATED.

 Brief Hospital Course: ___ y/o M with PMhx of CAD s/p CABG in ___, NSTEMI, systolic CHF(EF 35-40%), PVD s/p bypass, CKD stage III, history of LLE DVT s/p IVC filter, chronic SDH and Dementia who p/w acute encephalopathy 

# Acute on chronic SDH: patient was evaluated by neurosurgery, ___ noted to be stable on serial CTs. NSGY recommended holding ASA for 1 week and avoiding anticoagulation. ASA was restarted on ___. He will follow up after discharge with Dr. ___ neurology. Patient has an outpatient CT scheduled at the end of ___ for serial follow-up.

# Fevers # Sepsis # Encephalopathy # Pneumonia with parapneumonic effusion: Initially, patient thought to be altered secondary to UTI vs. PNA as CXR and CT demonstrated LLL consolidation. He was initially on ceftriaxone. UCx grew pan-susceptible E. COli and patient was transitioned to cepfodoxime and azithro for both UTI and PNA. However on evening of ___, patient developed sepsis with fever, hypotension and worsening leukocytosis. He was broadened to vanc and cefepime. WBC the following morning noted to be 25. CT C/A/P was ordered to evaluate for etiology of sepsis. CT demonstrated LLL collpasse and loculated effusion. Interventional pulm was consulted and placed a chest tube at the bedside. Pleural studies consistent with exudative effusion - cultures and cytology were however negative. WBC continued to rise to ___ and flagyl was added. ID was consulted and recommended ceftriaxone and flagyl given some concern for aspiration. His white count then began to improve. Repeat CT scan showed another area in the L lung with loculated effusion therefore a second chest tube was placed on ___ by ___ per family's request. ID recommended ceftriaxone and flagyl until ___ (further course to be determined at that time) and midline was placed however patient delirious overnight on ___ and pulled midline. He was therefore continued on IM ceftriaxone and PO flagyl to complete his course trhough ___

# Dementia # Delerium - patient with baseline dementia and fluctuations in behavior however worsened over past few days likely from prolonged admission as well as infection. He required prn zyprexa and Haldol in order for nursing to provide care. Psych was consulted on ___ and recommended standing Haldol as well as ramelteon to improve sleep wake cycle. 

# CT chest with LLL PNA vs. mass - CT chest findings as above, discussed with daughter, she preferred patient not to be informed of potential for cancer and only be told findings are due to a PNA. Cytology on initial thoracentesis was negative, ___ ___ was pending at time of discharge. 

# Acute kidney injury on CKD - patient with baseline CKD and Cr 1.2. He developed ___ on ___ likely in setting of sepsis as well as receiving IV contrast. His Cr peaked at 2.9. Diuretics were held. Urine studies were consistent with pre-renal etiology. Renal was consulted and recommended IVF for goal ___ input per day. His Cr improved and returned to baseline. 

 # Urinary retention - patient requiring frequent straight caths for large PVRs, likely in setting of large stool burden and constipation with overflow incontinence. He was started on Flomax and finasteride. Foley catheter was placed ___. Patient failed voiding trial on ___ Foley subsequently placed and started on tamsulosin with intent for voiding trial with urology.

# chronic systolic CHF: Initially Pt clinically volume overloaded, however now then appeared dry and developed ___. Diuretics and BB were held in setting of sepsis. Diuretics (torsemide) and KCl supplement still on hold at discharge.

# CAD s/p CABG: cont statin, BB, ASA restarted ___, Imdur restarted ___

TRANSITIONAL ISSUES - Diuretics were held at discharge. Please follow-up patient's volume and respiratory status and re-institute when able. - Please check chem 10 within one week of discharge for renal function - Patient failed inpatient voiding trial; started on tamsulosin and will need voiding trial at ___, and if fails, with ___ clinic. - Patient will need repeat chest imaging in ___ weeks to see if chest mass improved with antibiotics (concern for underlying malignancy). - In discussion with patient's daughter (HCP) she did not feel patient nor family would want treatment should mass turn out to be malignancy, and that this potential information should be withheld form him. - Patient will require follow-up NCHCT for ___ on ___. - Scheduled follow-up with neurosurgery - Antibiotic course with ceftriaxone and flagyl until ___ (further course to be determined at that time by ID appointment) - Patient significantly deconditioned, will need ___ - Patient started on standing Haldol by psychiatry for agitation; please monitor QTc and symptoms; adjust medicaitons as needed.

> 30 minutes spent coordinating discharge  Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 4. Metoprolol Succinate XL 25 mg PO DAILY 5. Metolazone 2.5 mg PO 3X/WEEK (___) 6. Phenytoin (Suspension) 300 mg PO 3X/WEEK (___) 7. Phenytoin (Suspension) 400 mg PO 4X/WEEK (___) 8. Potassium Chloride 20 mEq PO DAILY 9. Pantoprazole 40 mg PO Q24H 10. Torsemide 40 mg PO DAILY 11. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 12. Bisacodyl 10 mg PR QHS:PRN constipation 13. Milk of Magnesia 30 mL PO Q6H:PRN constipation 14. GuaiFENesin ___ mL PO Q6H:PRN cough 15. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 

 Discharge Medications: 1. CefTRIAXone 2 g IM Q24H To continue through ___, then transition to PO cefpodoxime 100 mg PO BID on ___.  2. Docusate Sodium 100 mg PO BID  3. Finasteride 5 mg PO DAILY  4. Haloperidol 2.5 mg PO BID  5. Lactulose 30 mL PO BID  6. MetroNIDAZOLE 500 mg PO/NG Q8H 6-week course due to end on ___.  7. Senna 17.2 mg PO BID  8. Tamsulosin 0.8 mg PO QHS  9. Vitamin D ___ UNIT PO 1X/WEEK (WE)  10. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  11. Aspirin 81 mg PO DAILY  12. Atorvastatin 80 mg PO QPM  13. Bisacodyl 10 mg PR QHS:PRN constipation  14. GuaiFENesin ___ mL PO Q6H:PRN cough  15. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY  16. Metoprolol Succinate XL 25 mg PO DAILY  17. Milk of Magnesia 30 mL PO Q6H:PRN constipation  18. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain  19. Pantoprazole 40 mg PO Q24H  20. Phenytoin (Suspension) 300 mg PO 3X/WEEK (___)  21. Phenytoin (Suspension) 400 mg PO 4X/WEEK (___) 

 Discharge Disposition: Extended Care  Facility: ___  Discharge Diagnosis: Sepsis UTI Pneumonia with parapneumonic effusion Chest tube placement Delirium Acute renal failure

 Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane).

 Discharge Instructions: Dear ___

___ were admitted for confusion and altered mental status. ___ were found to have a UTI as well as a pneumonia. ___ were treated with antibiotics however ___ developed a complication related to your pneumonia called an empyema or an infected fluid collection around your lung. ___ had 2 chest tubes placed to drain this fluid. ___ also developed acute renal failure which resolved with IV fluids.  Followup Instructions: ___ 